Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session VI: Hepatobiliary Cancers
Debate: Optimal Second-Line Treatment in Hepatocellular Carcinoma? Tyrosine Kinase Inhibitors vs. IO - IO
Thursday, April 21, 2022
2:55 PM – 3:03 PM
Debate Speaker(s)
Ghassan K. Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center